SPY337.44+4.64 1.39%
DIA280.04+2.85 1.03%
IXIC11,012.24+229.42 2.13%

H.C. Wainwright Initiates Coverage On Calithera Biosciences with Buy Rating, Announces $7 Price Target

H.C. Wainwright initiates coverage on Calithera Biosciences (NASDAQ:CALA) with a Buy rating and a $7 price target.

Benzinga · -

H.C. Wainwright initiates coverage on Calithera Biosciences (NASDAQ:CALA) with a Buy rating and a $7 price target.